Belviq Lawsuit

Belviq Cancer Lawsuit

Belviq, also known as lorcaserin, is a weight-loss drug. Belviq’s intended use was to curb users’ hunger, potentially leading to weight loss due to decreased consumption. Recently, researchers have revealed that Belviq can be harmful. Belviq’s intended use is to curve its user’s hunger, potentially leading to weight loss. Recently, researchers have revealed that Belviq could be harmful.

In early 2020 the FDA declared a recall of Belviq. Several studies showed the link between the drug and an increased risk of cancer. Instead of improving their health, hundreds of thousands of Belviq users unknowingly risked damaging it.

Making a case for the dangers of Belviq

In a five-year, double-blind study of 12,000 patients, users of Belviq were more likely to develop cancer compared to those taking a placebo. The FDA concluded Belviq caused several forms of cancer, including:

  • Lung cancer
  • Colorectal cancer
  • Pancreatic cancer

Eisai Inc, the Belviq and Belviq XR manufacturer should never have sold the drug to the public. They need to be held accountable for those diagnosed with cancer. If you took Belviq or a similar brand of lorcaserin and were diagnosed with cancer, please contact us for a free case review.